Guiot J, Miedema J, Cordeiro A, et al. Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease. Autoimmun Rev. 2024;23(6): 103582.

CAS  PubMed  Google Scholar 

Zou Qinghua Lu, Yuewu ZJ, et al. Diagnosis and treatment protocol for connective tissue disease-associated interstitial lung disease. Chin J Internal Med. 2022;61(11):1217–23.

Google Scholar 

Kaul B, Cottin V, Collard HR, et al. Variability in global prevalence of interstitial lung disease. Front Med (Lausanne). 2021;8: 751181.

PubMed  Google Scholar 

Ban C, Yan W, Xie B, et al. Spectrum of interstitial lung disease in China from 2000 to 2012. Eur Respir J. 2018;52(3):1701554.

PubMed  Google Scholar 

Luppi F, Sebastiani M, Salvarani C, et al. Acute exacerbation of interstitial lung disease associated with rheumatic disease. Nat Rev Rheumatol. 2022;18(2):85–96.

PubMed  Google Scholar 

Banuls L, Vanoverschelde J, Garnier F, et al. Interstitial lung disease worsens short- and long-term outcomes of systemic rheumatic disease patients admitted to the ICU: a multicenter study. J Clin Med. 2021;10(5):1037.

PubMed  PubMed Central  Google Scholar 

Suzuki A, Kondoh Y, Brown KK, et al. Acute exacerbations of fibrotic interstitial lung diseases. Respirology. 2020;25(5):525–34.

PubMed  Google Scholar 

Cerro Chiang G, Parimon T. Understanding interstitial lung diseases associated with connective tissue disease (CTD-ILD): genetics, cellular pathophysiology, and biologic drivers. Int J Mol Sci. 2023;24:2405.

CAS  PubMed  PubMed Central  Google Scholar 

Joy GM, Arbiv OA, Wong CK, Lok SD, Adderley NA, Dobosz KM, Johannson KA, Ryerson CJ. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis. Eur Respir Rev. 2023;32:220210.

PubMed  PubMed Central  Google Scholar 

Jee AS, Corte TJ. Current and emerging drug therapies for connective tissue disease-interstitial lung disease (CTD-ILD). Drugs. 2019;79:1511–28.

PubMed  Google Scholar 

2022 guidelines for the diagnosis and treatment of connective tissue disease-associated interstitial lung disease

Yoo H, Hino T, Hwang J, et al. Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): evolving concept of CT findings, pathology and management. Eur J Radiol Open. 2022;9: 100419.

PubMed  PubMed Central  Google Scholar 

Walsh SL, Sverzellati N, Devaraj A, Keir GJ, Wells AU, Hansell DM. Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants. Thorax. 2014;69(3):216–22.

PubMed  Google Scholar 

Marinescu DC, Hague CJ, Muller NL, et al. CT honeycombing and traction bronchiectasis extent independently predict survival across fibrotic interstitial lung disease subtypes. Radiology. 2025;314(2): e241001.

PubMed  Google Scholar 

Spagnolo P, Distler O, Ryerson CJ, Tzouvelekis A, Lee JS, Bonella F, Bouros D, Hoffmann-Vold AM, Crestani B, Matteson EL. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs). Ann Rheum Dis. 2021;80:143–50.

CAS  PubMed  Google Scholar 

Oldham JM, Lee CT, Wu Z, Bowman, et al. Lung function trajectory in progressive fibrosing interstitial lung disease. Eur Respir J. 2022;59:2101396.

CAS  PubMed  PubMed Central  Google Scholar 

Drakopanagiotakis F, Markart P, Steiropoulos P. Acute exacerbations of interstitial lung diseases: focus on biomarkers. Int J Mol Sci. 2023;24(12):10196.

CAS  PubMed  PubMed Central  Google Scholar 

Ishikawa G, Acquah SO, Salvatore M, et al. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease. Respir Med. 2017;128:78–84.

PubMed  Google Scholar 

Zhang T, Shen P, Duan C, et al. KL-6 as an immunological biomarker predicts the severity, progression, acute exacerbation, and poor outcomes of interstitial lung disease: a systematic review and meta-analysis. Front Immunol. 2021;12: 745233.

CAS  PubMed  PubMed Central  Google Scholar 

Akiyama M, Kaneko Y, Yamaoka K, et al. Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study. Rheumatol Int. 2016;36(6):881–9.

CAS  PubMed  Google Scholar 

Cao H, Huan C, Wang Q, et al. Predicting survival across acute exacerbation of interstitial lung disease in patients with idiopathic inflammatory myositis: the GAP-ILD model. Rheumatol Ther. 2020;7(4):967–78.

PubMed  PubMed Central  Google Scholar 

Xiaofei Z. Clinical characteristics and risk factor analysis of pulmonary infection in patients with connective tissue disease-associated interstitial lung disease. Guangzhou: Guangzhou Medical University; 2018.

Google Scholar 

Spagnolo P, Distler O, Ryerson CJ, et al. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs). Ann Rheum Dis. 2021;80(2):143–50.

CAS  PubMed  Google Scholar 

Juge PA, Borie R, Kannengiesser C, et al. Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis. Eur Respir J. 2017;49(5):1602314.

PubMed  Google Scholar 

Akiyama M, Kaneko Y. Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease. Autoimmun Rev. 2022;21(5):103056.

CAS  PubMed  Google Scholar 

Liang J, Cao H, Ke Y, et al. Acute exacerbation of interstitial lung disease in adult patients with idiopathic inflammatory myopathies: a retrospective case-control study. Front Med (Lausanne). 2020;7:12.

PubMed  Google Scholar 

Kim H, Cho SK, Song YJ, et al. Clinical characteristics of rheumatoid arthritis patients with interstitial lung disease: baseline data of a single-center prospective cohort. Arthritis Res Ther. 2023;25(1):43.

CAS  PubMed  PubMed Central  Google Scholar 

McFarlane IM, Zhaz SY, Bhamra MS, et al. Assessment of interstitial lung disease among black rheumatoid arthritis patients. Clin Rheumatol. 2019;38(12):3413–24.

PubMed  Google Scholar 

Respiratory Council of Chinese Research Hospital Association. Expert consensus on the management of interstitial lung disease during the COVID -19 epidemic. Zhonghua Jie He He Hu Xi Za Zhi. 2023;46(12):1204–18.

Google Scholar 

Mathai SC, Danoff SK. Management of interstitial lung disease associated with connective tissue disease. BMJ. 2016;352:6819.

Google Scholar 

Chen HH, Yong YM, Lin CH, et al. Air pollutants and development of interstitial lung disease in patients with connective tissue disease: a population-based case-control study in Taiwan. BMJ Open. 2020;10(12):e041405.

PubMed  PubMed Central  Google Scholar 

Qiaozhen Xu, Huixue Z, Huijuan H. Clinical characteristics and risk factors of pulmonary infection in patients with connective tissue disease-associated interstitial lung disease. Heilongjiang Med Pharm. 2024;37(2):390–3.

Google Scholar 

Shao T, Shi X, Yang S, et al. Interstitial lung disease in connective tissue disease: a common lesion with heterogeneous mechanisms and treatment considerations. Front Immunol. 2021;12: 684699.

CAS  PubMed  PubMed Central  Google Scholar 

Gagiannis D, Steinestel J, Hackenbroch C, et al. Clinical, serological, and histopathological similarities between severe COVID-19 and acute exacerbation of connective tissue disease-associated interstitial lung disease (CTD-ILD). Front Immunol. 2020;11: 587517.

CAS  PubMed  PubMed Central  Google Scholar 

Hayat Syed MK, Bruck O, et al. Acute exacerbation of interstitial lung disease in the intensive care unit: principles of diagnostic evaluation and management. World J Crit Care Med. 2023;12(3):153–64.

PubMed  PubMed Central  Google Scholar 

Singh P, Thakur B, Mohapatra AK, et al. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: a single-center study from India. Int J Rheum Dis. 2019;22(9):1741–5.

CAS  PubMed  Google Scholar 

Krishnan A, Janz DR, Lammi MR. ICU management of the patient with fibrotic interstitial lung disease. CHEST Crit Care. 2023;1:100020.

Google Scholar 

Arevalo C, Nagel D. Acute exacerbations of interstitiallung disease: evolving perspectives on diagnosis and management. Fibrosis. 2024;2(4):10008.

Google Scholar 

Gao Y, Moua T. Treatment of the connective tissue disease-related interstitial lung diseases: a narrative review. Mayo Clin Proc. 2020;95(3):554–73.

CAS  PubMed  Google Scholar 

Trudzinski FC, Kaestner F, Schäfers HJ, Fähndrich S, Seiler F, Böhmer P, Linn O, Kaiser R, Haake H, Langer F, Bals R, Wilkens H, Lepper PM. Outcome of patients with interstitial lung disease treated with extracorporeal membrane oxygenation for acute respiratory failure. Am J Respir Crit Care Med. 2016;193(5):527–33.

CAS  PubMed  Google Scholar 

Xiong A, Luo W, Tang X, et al. Risk factors for invasive fungal infections in patients with connective tissue disease: systematic review and meta-analysis. Semin Arthritis Rheum. 2023;63: 152257.

CAS  PubMed  Google Scholar 

Manfredi A, Sebastiani M, Cerri S, et al. Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature. J Thorac Dis. 2019;11(4):1621–8.